BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1434 related articles for article (PubMed ID: 18759926)

  • 1. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT; Bluestone JA
    Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is CTLA-4 a master switch for peripheral T cell tolerance?
    Bluestone JA
    J Immunol; 1997 Mar; 158(5):1989-93. PubMed ID: 9036940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the PD-1 pathway in autoimmunity and peripheral tolerance.
    Fife BT; Pauken KE
    Ann N Y Acad Sci; 2011 Jan; 1217():45-59. PubMed ID: 21276005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B7 family revisited.
    Greenwald RJ; Freeman GJ; Sharpe AH
    Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B7-CD28 superfamily.
    Sharpe AH; Freeman GJ
    Nat Rev Immunol; 2002 Feb; 2(2):116-26. PubMed ID: 11910893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PD-1/PD-Ls pathway and autoimmune diseases.
    Dai S; Jia R; Zhang X; Fang Q; Huang L
    Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical inhibition of T-cell function in response to CTLA-4 blockade; heterogeneity within the human T-cell population.
    Anderson DE; Bieganowska KD; Bar-Or A; Oliveira EM; Carreno B; Collins M; Hafler DA
    Nat Med; 2000 Feb; 6(2):211-4. PubMed ID: 10655112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.
    Oikawa T; Takahashi H; Ishikawa T; Hokari A; Otsuki N; Azuma M; Zeniya M; Tajiri H
    Pathol Int; 2007 Aug; 57(8):485-92. PubMed ID: 17610472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
    Schwartz JC; Zhang X; Fedorov AA; Nathenson SG; Almo SC
    Nature; 2001 Mar; 410(6828):604-8. PubMed ID: 11279501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4: a key regulatory point in the control of autoimmune disease.
    Scalapino KJ; Daikh DI
    Immunol Rev; 2008 Jun; 223():143-55. PubMed ID: 18613834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Manipulation of costimulatory pathways in autoimmune disease].
    Kaneko H; Nakajima A; Azuma M
    Nihon Rinsho; 1997 Jun; 55(6):1531-6. PubMed ID: 9200944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
    Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
    Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses.
    Wang S; Chen L
    Microbes Infect; 2004 Jul; 6(8):759-66. PubMed ID: 15207823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.